Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report

No standard has been established for salvage therapy in gemcitabine refractory advanced urothelial cancer. We report the complete response to FOLFOX4 therapy of a metastatic urothelial cancer patient, for whom adjuvant gemcitabine plus cisplatin combination chemotherapy had failed. A 54-year-old mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Yu Ri, Kim, Se Hyung, Kim, Hyun Jung, Kim, Chan Kyu, Park, Seong Kyu, Koh, Eun Suk, Hong, Dae Sik
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818621/
https://www.ncbi.nlm.nih.gov/pubmed/20089186
http://dx.doi.org/10.1186/1756-8722-3-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818621/
https://www.ncbi.nlm.nih.gov/pubmed/20089186
http://dx.doi.org/10.1186/1756-8722-3-4

Ejemplares similares